Cargando…
A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with “intentional internal high-dose policy” high-dose-rate interstitial brachytherapy
RATIONALE: Gynecological high-dose-rate (HDR) brachytherapy has progressed for years, but it remains difficult for bulky tumors to be controlled locally. Dose limitations to organs at risk (OARs) are invariably obstacles in increasing the prescription dose. Additionally, it is controversial that the...
Autores principales: | Kashihara, Tairo, Kobayashi, Kazuma, Iijima, Kotaro, Murakami, Naoya, Yoshida, Ken, Okuma, Kae, Nakamura, Satoshi, Takahashi, Kana, Inaba, Koji, Igaki, Hiroshi, Nakayama, Yuko, Kato, Tomoyasu, Uno, Takashi, Itami, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337609/ https://www.ncbi.nlm.nih.gov/pubmed/32629674 http://dx.doi.org/10.1097/MD.0000000000020860 |
Ejemplares similares
-
Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic
por: Murakami, Naoya, et al.
Publicado: (2021) -
Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction
por: Murakami, Naoya, et al.
Publicado: (2019) -
Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies
por: Murakami, Naoya, et al.
Publicado: (2022) -
Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience
por: Kashihara, Tairo, et al.
Publicado: (2019) -
High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note
por: Shimizu, Yuri, et al.
Publicado: (2022)